KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Globus Medical (GMED) Cash from Investing Activities (2016 - 2026)

Globus Medical filings provide 15 years of Cash from Investing Activities readings, the most recent being -$111.4 million for Q4 2025.

  • On a quarterly basis, Cash from Investing Activities fell 7.04% to -$111.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was -$355.0 million, a 101.65% decrease, with the full-year FY2025 number at -$355.0 million, down 101.65% from a year prior.
  • Cash from Investing Activities hit -$111.4 million in Q4 2025 for Globus Medical, down from -$75.8 million in the prior quarter.
  • In the past five years, Cash from Investing Activities ranged from a high of $320.6 million in Q4 2023 to a low of -$299.1 million in Q2 2025.
  • Median Cash from Investing Activities over the past 5 years was -$30.8 million (2024), compared with a mean of -$35.7 million.
  • Biggest five-year swings in Cash from Investing Activities: crashed 4726.93% in 2021 and later skyrocketed 19069.23% in 2022.
  • Globus Medical's Cash from Investing Activities stood at -$243.8 million in 2021, then soared by 75.19% to -$60.5 million in 2022, then skyrocketed by 630.08% to $320.6 million in 2023, then plummeted by 132.48% to -$104.1 million in 2024, then fell by 7.04% to -$111.4 million in 2025.
  • The last three reported values for Cash from Investing Activities were -$111.4 million (Q4 2025), -$75.8 million (Q3 2025), and -$299.1 million (Q2 2025) per Business Quant data.